Australian doctors to evaluate Bhutanese conjoined twins before operation | WeForNews | Latest News, Blogs Australian doctors to evaluate Bhutanese conjoined twins before operation – WeForNews | Latest News, Blogs
Connect with us

Health

Australian doctors to evaluate Bhutanese conjoined twins before operation

Published

on

Doctors

Melbourne, Oct 4: A pair of Bhutanese twins who were born 14 months ago conjoined at the chest will be evaluated on Thursday at a hospital in Australia before undergoing separation surgery.

“We need to just double check everything is alright generally,” anesthesiologist Ian McKenzie, a member of the specialist medical team at the Royal Children’s Hospital here where the complicated procedure will take place, told the media.

The twins Nima and Dawa Pelden, who arrived in Australia on Tuesday, will undergo high-quality image scans to determine whether they are ready for the planned operation, reports Efe news.

“There’s a whole lot of things they might have got in Bhutan they wouldn’t get in Australia, and we need to just have our guard up that they haven’t got a surprise illness we haven’t thought of, that might not be very common here,” McKenzie said.

Based on the results of the analysis, doctors will schedule the operation, which could be carried out next week and would last about eight hours.

Hospital head paediatric surgeon Joe Crameri said that the twins seem to be fine because they are active and interacting with each other.

The twins were born on July 13, 2017, via a C-section delivery in Bhutan. They are the first known conjoined twins in their country.

IANS

Health

Karnataka rejects probe into COVID purchases, Oppn walks out of House

Published

on

By

Yediyurappa Karnataka

Bengaluru, Sep 23 : After the opposition demand for a judicial inquiry into procurements made during the COVID-19 pandemic was rejected, opposition Congress lawmakers led by Siddaramaiah walked out of the Assembly in protest on Wednesday.

Karnataka Medical Education Minister Dr K Sudhakar earlier asserted that there was no corruption in any of the procurements done during the pandemic.

Replying to a debate on alleged procurement scams pointed out by opposition parties in the Assembly, Sudhakar said that there was no deviation of funds or corruption. “So, where is the question of ordering a probe? The state government rejects all allegations made by the Opposition,” the Minister said.

He charged the opposition lawmakers with trying to derive political mileage which he said was demoralising officials and Corona Warriors.

According to him, ventilators procured by the Tamil Nadu government are transport ventilators used in ambulances. “Hence, it is not correct to compare our ventilators with those in Tamil Nadu. Ventilators of different specifications and quality are available for different prices; one should not get confused with different prices,” he maintained.

The Minister asserted that the market prices vary as per the demand, and the procurement is done on the basis of prevailing prices.

“There is no instance of corruption in the procurement of equipment for the COVID-19 pandemic in the state. Not even a single deviation has taken place and, therefore, there is no need for an investigation,” he asserted.

“When there was no domestic production, we procured three lakh PPE kits from China. Subsequently, we decided to purchase from local manufacturers, that too ICMR-approved kits. Similar procedures were followed by other states as well,” the Minister explained.

He said there was shortage of sanitisers in the state but after talks with distillery owners, the demand has since been met.

Earlier, several opposition leaders, including Leader of Opposition Siddaramaiah accused the state government of indulging in rampant corruption during the pandemic.

“Be it the purchase of ventilators, beds, medicines, or PPE kits, every procurement was cleared only after a cut. Hence, it is necessary to order a judicial inquiry by a sitting High Court Judge,” he said, as other opposition members endorsed his views.

Continue Reading

Health

World Pharmacists Day 2020: Date, theme, all you need to know about this day

World Pharmacists Day: The purpose of the day is to draw attention to pharmacies and the positive benefits they offer when it comes to health and FIP encourages all its members to participate to make the event a success.

Published

on

By

Paracetamol Medicine Ibuprufen

World Pharmacists Day was an initiative of the International Pharmaceutical Federation (FIP) along with the council of this organization who voted to establish the event in the late 2000s during a conference held in Istanbul, Turkey. The purpose of the day is to draw attention to pharmacies and the positive benefits they offer when it comes to health and FIP encourages all its members to participate to make the event a success.

World Pharmacists Day 2020 Date and theme:

World Pharmacists Day is observed every year on September 25. This year’s theme is “Transforming global health“.

“We aim to show how pharmacists contribute to a world where everyone benefits from access to safe, effective, quality and affordable medicines and health technologies, as well as from pharmaceutical care services,” said FIP President Dominique Jordan.

Why World Pharmacist Day is celebrated?

The aim of World Pharmacists Day, which was implemented at the FIP Council 2009 in Istanbul, is to encourage activities that promote and advocate the role of the pharmacist in improving health in all corners of the world.

Pharmacists are the reason people get the best benefit from medicine. They use their experience, knowledge and expertise to make the (medical) world a better place for everyone. In addition, they enable people to obtain medicines, give people advice on how to take them correctly, and so on.

Why is it celebrated on September 25?

The Turkish members of FIP suggested the Date because the FIP was established on the same day in 1912.

About International Pharmaceutical Federation (FIP):

The founder of World Pharmacists Day, the International Pharmaceutical Federation (FIP) is the global body representing pharmacy, pharmaceutical sciences, and pharmaceutical education. Through their 144 national organisations, academic institutional members and individual members, they represent millions of pharmacists, pharmaceutical scientists and pharmaceutical educators around the world. FIP is a non-governmental organisation with its head office in the Netherlands.

The organization announces a different theme every year so that associations and individuals in the pharmaceutical industry can organize national campaigns or local projects to showcase their outstanding work in helping improve the health of people around the world.

This can include holding lectures, holding exhibitions or organizing activity days for adults and children to showcase the many ways the pharmacy can help them.

Continue Reading

Health

CSIR and Mylan Announce Partnership to identify Advance Therapeutic Options for Management of COVID – 19

“CSIR has prioritized conducting clinical trials of well proven drugs in partnership with industry towards the development of multiple therapeutic options for COVID-19.” : Director General of CSIR, Dr. Shehkar C Mande

Published

on

Vaccine

New Delih: The Council of Scientific & Industrial Research (CSIR), India’s premier research organization, and Mylan Laboratories Limited, the India-based subsidiary of leading global pharmaceutical company Mylan, today announced a partnership to address unmet patient needs amidst the evolving COVID-19 pandemic. Under the partnership, CSIR’s constituent laboratory Indian Institute of Chemical Technology (CSIR-IICT), and Mylan will collaborate to identify potential therapies for COVID-19.

A series of clinical trials will be conducted towards new and innovative solutions to manage COVID-19 pandemic in India as part of this collaboration. The first of the clinical trial to be rolled out is a multiple arm phase 3 study that will be conducted in adult patients with mild to moderate COVID -19 at risk of complications.

Director General of CSIR, Dr. Shehkar C Mande stated, “The current collaboration with Mylan is a significant milestone and during the current COVID-19 pandemic, CSIR has prioritized conducting clinical trials of well proven drugs in partnership with industry towards the development of multiple therapeutic options for COVID-19.”

Director of CSIR-IICT, Dr Chandrasekhar said, “CSIR is delighted to associate with Mylan as knowledge and scientific partner, and looks forward to working with the company, especially given Mylan’s vast industry experience in clinical trials and commercialization.”

Mylan Chief Operating Officer, Sanjeev Sethi stated, “Our collaboration with CSIR is a strategic step forward aimed at identifying effective treatments for patients with COVID-19. In addition to bringing forward new indications, this partnership will also help us identify multiple molecules that can potentially be leveraged in therapies for various other infectious diseases in the future.”

The application for the clinical trials has been submitted to the Drugs Controller General of India (DCGI) for regulatory approval.

CSIR has appointed Dr. Ram Vishwakarma, Honorary Advisor to DG-CSIR and former Director CSIR-IIIM (Indian Institute of Integrative Medicine) as a mentor to lead this collaboration.

The Council of Scientific & Industrial Research (CSIR), known for its cutting-edge R&D knowledgebase in diverse Science & Technology areas, is a contemporary and premier R&D organization. Having a pan-India presence, CSIR has a dynamic network of 38 national laboratories, 39 outreach centres, 3 Innovation Complexes and 5 units. CSIR covers a wide spectrum of science and technology – from oceanography, geophysics, chemicals, drugs, genomics, biotechnology and nanotechnology to mining, aeronautics, instrumentation, environmental engineering and information technology.

Mylan is a global pharmaceutical company committed to setting new standards in healthcare. It is one of the world’s largest producers of active pharmaceutical ingredients.

Continue Reading
Advertisement

Most Popular

Corona Virus (COVID-19) Live Data

COVID-19 affects different people in different ways. Most infected people will develop mild to moderate illness and recover without hospitalization.